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A membrane proximal region of the integrin α5 subunit is important for its
interaction with nischarin
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In a previous study [Alahari, Lee and Juliano (2000) J. Cell Biol.
151, 1141–1154], we have identified a novel protein, nischarin,
that specifically interacts with the cytoplasmic tail of the α5
integrin subunit. Overexpression of this protein profoundly affects
cell migration. To examine the nischarin–α5 interaction in detail,
and to find the minimal region required for the interaction, sev-
eral mutants of nischarin and α5 were created. The results obtained
for the yeast two-hybrid system indicate that a 99-aminoacid
region of nischarin (from residues 464 to 562) is indispensable
for the interaction. Also, we demonstrate that the membrane
proximal region (from residues 1017 to 1030) of the α5 cyto-
plasmic tail is essential for the interaction. To characterize more
directly the properties of the interaction between nischarin and
α5, we performed surface-plasmon resonance studies in which
peptides were immobilized on the surface of a sensor chip, and the
recombinant nischarin protein fragments were injected. Consis-
tent with the two-hybrid results, recombinant nischarin binds well
to immobilized α5 peptides. In addition, mutational analysis re-
vealed that residues Tyr1018 and Lys1022 are crucial for α5–nischarin
interactions. These results provide evidence that nischarin is capa-
ble of directly and selectively binding to a portion of the α5
cytoplasmic domain. Further studies demonstrated that the mini-
mal α5 binding region of nischarin does not affect cell migration.
Key words: biacore, integrin, migration, nischarin, yeast two-
hybrid.
INTRODUCTION
Integrins consist of three domains: extracellular, transmembrane
and intracellular regions. Integrin cytoplasmic domains articulate
directly or indirectly with a number of cytoskeletal proteins, inclu-
ding actin, vinculin, talin, paxillin, as well as signalling molecules,
including Src, FAK (focal adhesion kinase), Ras, Raf, MAPK
(mitogen-activated protein kinase), MEK (MAPK/ERK kinase)
and c-Jun N-terminal kinase [1–3]. This suggests that integrins
play an important role in converging signals from the membrane
to the inside of cells (outside in signalling). The β cytoplasmic
domains have been shown to play a major role in integrin-
mediated signal-transduction events [4]. In addition, β cyto-
plasmic domains are required for cell spreading, particularly that
mediated by R-Ras, phosphoinositide 3-kinase and Rac1 [5], and
for the regulation of fibronectin binding by αvβ3 [6]. The role of
α subunits in integrin function is not very well known. However,
several reports indicate that the α cytoplasmic tails are important
in signalling through interaction with calreticulin [7,8], and
essential for stress fibre formation and cell migration in CHO
(Chinese-hamster ovary) cells [9]. In contrast, the cytoplasmic
tails of α4 and α9 inhibit cell spreading and enhance cell migration
[10]. All α integrin subunits are characterized by highly conserved
GFFKR regions. Whereas many proteins have been shown to bind
to β integrin cytoplasmic domains [11–13], only a few proteins
have been shown to bind to α subunits. These include calcium-
and integrin-binding protein binding to the αIIb cytoplasmic tail
[14], talin binding to the cytoplasmic tails of αIIb and β3 [15],
paxillin binding to the α4 cytoplasmic tail [16] and nischarin
binding to the α5 cytoplasmic domain [17].
We previously reported that the α5 cytoplasmic region selec-
tively interacts with nischarin. By yeast two-hybrid analysis and
co-immunoprecipitation experiments, nischarin has been shown
to interact with the α5 integrin subunit more strongly than any
other integrin subunit tested [17]. Although nischarin is ubiqui-
Abbreviations used: CHO, Chinese-hamster ovary; DSC, differential-scanning calorimetry; GST, glutathione S-transferase; IBD, integrin-binding domain;
MIBD, minimal IBD; NIBD, non-IBD.
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tously expressed, it is most highly expressed in neuronal cells.
Nischarin is a protein of 190 kDa (measured molecular mass),
and its overexpression inhibits cell migration and affects the
actin cytoskeleton. This inhibitory effect was more dramatic when
cells migrated on fibronectin matrix, mediated by α5, compared
with cells migrating on matrices mediated by other integrins.
Our recent results indicate that nischarin selectively inhibits Rac-
driven cell migration through p21-activated kinase [18].
The exact interacting regions on α5 as well as on nischarin
have not been mapped. To understand further the interaction, we
used a chimaeric yeast two-hybrid system to map the binding
domain of nischarin. In the present study, we describe a mini-
mal domain containing 99 amino acids as the essential region
for the interaction with the α5 integrin subunit. The interactions
detected by two-hybrid analysis were further validated using
surface-plasmon resonance studies. To explore the importance
of specific sequences in α5 for binding to nischarin, we analysed
the binding of nischarin truncations to full-length α5 cytoplasmic
tail as well as binding of a series of α5 peptides to nischarin. Our
results show that the IYILYKLGFFKRSL sequence is required
for the formation of nischarin–α5 complex as monitored by
BIAcore analysis, whereas Tyr1018 and Lys1022 seem to be crucial
for the interaction. In addition, functional studies showed that the
MIBD (minimal integrin-binding domain) of nischarin did not
have any effect on α5-mediated cell motility indicating that the




Streptavidin chips for plasmon resonance studies were purchased
from BIAcore (Piscataway, NJ, U.S.A.). Oligonucleotides were
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Table 1 Primers used to make truncations of IBD of Nischarin
IBD construct Primer Site
Trunc 1 5′-CAGCGGCCGCTCAAGCTGGAGTGGGCCCTGGGC-3′, 5′-CAGCGGCCGCGCTGCCGTAGAGGATGGG-3′ Not I
Trunc 2 5′-CAGCGGCCGCTCAAGGATGAGGACTTCCTGCTG-3′, 5′-CAGCGGCCGCGCTGCCGTAGAGGATGGG-3′ Not I
Trunc 3 5′-CAGCGGCCGCTCAAGATCCTCAAGGTGCTCTGG-3′, 5′-CAGCGGCCGCGCTGCCGTAGAGGATGGG-3′ Not I
Trunc 3.1 5′-CAGCGGCCGCTCAAGAAGGTGCTCTGGTGCTTC-3′, 5′-CAGCGGCCGCGCTGCCGTAGAGGATGGG-3′ Not I
Trunc 3.2 5′-CAGCGGCCGCTCAAGTGGTGCTTCCTGATCCAC-3′, 5′-CAGCGGCCGCGCTGCCGTAGAGGATGGG-3′ Not I
Trunc 3.3 5′-CAGCGGCCGCTCAAGCTGATCCACGTGCAAGGC-3′, 5′-CAGCGGCCGCGCTGCCGTAGAGGATGGG-3′ Not I
Trunc 4 5′-CAGCGGCCGCTCAAGCACGTGCAAGGCAGCATC-3′, 5′-CAGCGGCCGCGCTGCCGTAGAGGATGGG-3′ Not I
Trunc 11 5′-CAGCGGCCGCGGCCATGTGCTGCGGTGC-3′, 5′-CAGCGGCCGCTCAAGGACGAGGAGGCGGAGGAG-3′ Not I
Trunc 12 5′-CAGCGGCCGCGCGTAGATCAGCATGGAA-3′, 5′-CAGCGGCCGCTCAAGGACGAGGAGGCGGAGGAG-3′ Not I
Trunc 13 5′-CAGCGGCCGCGGCAGCATCCGAGATGATGAA-3′, 5′-CAGCGGCCGCTCAAGGACGAGGAGGCGGAGGAG-3′ Not I
Trunc 14 5′-CAGCGGCCGCCTCACTGTGCCGCACCTT-3′, 5′-CAGCGGCCGCTCAAGGACGAGGAGGCGGAGGAG-3′ Not I
Table 2 Primers used to make truncations of α5 cytoplasmic domain
α5 construct Primer Site
Trunc 1 5′-GGGAATTCAAGCTTGGATTCTTCAAACGCTCCCTCCCATATGGCACCGCCTG-3′ EcoRI
5′-GGCTGCAGGGCATCAGAGGTGGCTGGAGGCTTGAGCTGAGCTTTTTCCATGGCGGTGCCATATGG-3′ Pst I
Trunc 2 5′-GGGAATTCGGATTCTTCAAACGCTCCCTCCCATATGGCACCGCCATG-3′ EcoRI
5′-GGCTGCAGGGCATCAGAGGTGGCTGGAGGCTTGAGCTGAGCTTTTTCCATGGCGGTGCCATATGG-3′ Pst I
Trunc 3 5′-GGGAATTCTCCCTCCCATAT-3′ EcoRI
5′-GAGGATCCGGCATCAGAGGT-3′ BamHI
Trunc 11 5′-GACTGCAGTGGAGGCTTGAGCTGAGCTTTTTCCATGGCGGTGCCATATGGGAGGGAGCGTTTGAA-3′ EcoRI
5′-GAGAATTCATCTACATCCTCTACAAGCTTGGATTCTTCAAACGCTCCCTC-3′ Pst I
Trunc 12 5′-GACTGCAGCTGAGCTTTTTCCATGGCGGTGCCATATGGGAGGGAGCGTTTGAA-3′ EcoRI
5′-GAGAATTCATCTACATCCTCTACAAGCTTGGATTCTTCAAACGCTCCCTC-3′ Pst I
Trunc 13 5′-GAGAATTCATCTACATCCTCTACAAGCTTGGATTCTTC-3′ EcoRI
5′-GACTGCAGTCAGAGGGAGCGTTTGAAGAATCCAAGCTT-3′ Pst I
synthesized by the University of North Carolina (UNC) DNA
core facility. Peptides conjugated with biotin at the N-terminus
were synthesized by the UNC peptide synthesis core facility.
Construction of plasmids
To map the minimal interaction region on the α5 cytoplasmic tail
as well as on the IBD of nischarin, we prepared several constructs
as described below.
IBD constructs
The constructs were based on the IBD of nischarin previously
reported by us [17]. All IBD constructs were synthesized by using
full-length nischarin as the template and amplified by PCR
using the appropriate primers (see Table 1). The resulting frag-
ments were digested with NotI and fused to the VP16 trans-
activating domain of pVP16 vector (Table 1). The N-terminal
truncations were 1–4, 3.1, 3.2 and 3.3, and the C-terminal trun-
cations were 11–14. All the constructs were confirmed by
sequencing.
α5 constructs
All α5 truncations were constructed as lex A DNA-binding
fusions in the vector pBTM116. DNA fragments of truncated
versions of the integrin α5 cytoplasmic domain were amplified by
PCR using the appropriate primers (see Table 2). These fragments
were generated using full-length α5 cDNA as template, or simply
by fill-in extensions using approx. 60-mer oligonucleotide primers
(see Table 2). The fragments were subcloned into pBTM 116
utilizing either BamHI/EcoRI or PstI/EcoRI sites. N-terminal
Table 3 Primers used to make GST-IBD, GST-MIBD and GST-NIBD







truncations are trunc 1–3 and C-terminal fragments are trunc 11–
13. All constructs were confirmed by DNA sequencing.
Glutathione S-transferase (GST) constructs
Three GST-fusion constructs were prepared as shown in Table 3.
Fragments were amplified by PCR with the appropriate primers
(see Table 3) and subcloned into GST vector (pGEX5X.1; Amer-
sham Biosciences, Piscataway, NJ) in the XhoI/EcoRI region
as GST fusions and confirmed by sequencing. We made three
GST-fusion plasmids: (i) GST-IBD, GST fused to the originally
described IBD (residues 435–581); (ii) GST-MIBD, GST fused
to MIBD (residues 464–562) as determined here by yeast two-
hybrid approach; and (iii) GST-NIBD (where NIBD stands for
non-IBD), GST fused to a region of the MIBD that cannot bind
to α5 as identified by two-hybrid analysis (residues 469–534)
(Table 3).
Myc constructs
To generate Myc-tagged IBD, MIBD and NIBD, the respective
sequences were isolated by PCR as described for GST constructs
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and inserted into pcDNA3.1 vector (Invitrogen, Carlsbad, CA,
U.S.A). Primers for these constructs were exactly the same as for
GST constructs except that we included a Kozak sequence (GCC-
ACCATGG).
Yeast two-hybrid screening
Interactions of α5 integrin cytoplasmic domain constructs and
the IBD region of nischarin were examined using a yeast two-
hybrid system in L40 yeast strain [17]. These plasmids were
introduced into cells by the standard lithium acetate method,
and the interaction was examined by screening for histidine
prototrophy and Lac Z positivity. All these experiments were
performed as described previously [17].
Protein purification
GST-fusion constructs were transformed into BL21 cells. GST–
nischarin fusion proteins were purified as described previously
[17] with minor modifications. Briefly, the proteins were induced
with IPTG, and the cells were lysed in NETN buffer (20 mM
Tris/100 mM NaCl/1 mM EDTA/0.5% Nonidet P40) [17] with
aprotinin, and EDTA-free protease inhibitor cocktail tablet (Roche
Biochemicals). The lysates were sonicated, spun down, and both
the pellet and supernatant fractions were saved. Since these pro-
teins were not soluble, the pellet fraction was solubilized in a
buffer containing 10 mM Tris (7.8), 150 mM NaCl, 1 mM EDTA
and 0.5% N-dodecanoylsarcosine along with protease inhibitors.
The proteins were visualized by SDS/PAGE followed by staining
with Coomassie Blue. Proteins were immobilized on to gluta-
thione beads and the proteins that bound to glutathione–Sepharose
beads were eluted with 50 mM glutathione and dialysed against
PBS with Mg2+ and Ca2+ buffer. The concentration and purity of
the proteins were estimated by comparing with BSA standards on
a Coomassie Blue-stained SDS/polyacrylamide gel. Before using
in BIAcore assays, GST-fusion proteins were further verified for
purity and apparent molecular mass by size-exclusion chromato-
graphy using HiPrep 16/60 Sephacryl S-100 column, running on
an AKTA-FPLC (Amersham Biosciences).
Surface-plasmon resonance with BIAcore
Binding analyses were performed by surface-plasmon resonance
using a BIAcore 2000; these experiments were performed at
the University of North Carolina Macromolecular Interactions
facility. Sensor chips were activated by using the NaCl/NaOH
buffer according to the manufacturer’s specifications.
Surface-plasmon resonance experiments were performed as
described previously [19,20]. 5′-Biotinylated 14-residue α5
peptides (Table 4) were immobilized on the streptavidin-coated
surface of the sensor chip (sensor chip SA, BIAcore). All pep-
tides were diluted to 100 µM in the BIAcore buffer and they
were injected at a flow rate of 10 µl/min. The injections were
stopped once the immobilization of the peptide reached 300 re-
sonance units (RU) on the chip. Fusion proteins were diluted
to 40 nM in the running buffer and injected at a flow rate of
20 µl/min for 3 min. All proteins were injected using the kinject
command. Sometimes, the injections with GST-fusion proteins
were repeated to ensure that the surface-immobilized peptides
on the sensor chip were saturated with GST-fusion proteins.
Proteins bound to the sensor chip were allowed to disassociate
for 180 s before the surface was regenerated with 0.05% SDS.
The resulting sensorgrams were edited using the BIAevaluation
software (version 3.0). For re-usage, the chip was washed using
the quickinject command with 0.05% SDS at a flow rate of










20 µl/min, and the injected volume was 5 µl. After this quick
injection, the chip was washed with 100 µl of BIAcore buffer at
a flow rate of 20 µl/min.
Differential-scanning calorimetry (DSC)
DSC experiments were performed using a Microcal VP differen-
tial-scanning calorimeter (Microcal Incorporated, Northampton,
MA, U.S.A.) at the UNC Macromolecular Interactions Facility.
This technique is one of the best methods to evaluate protein-
unfolding transitions. GST and GST-MIBD proteins were purified
as described above. The protein was dialysed overnight against
2 litres of PBS that was used to establish the baseline. The sample
solutions and buffer were filtered and degassed under vacuum.
The calorimetric samples were pressurized and scanned from
20 to 95 ◦C at a rate of 1◦/min and protein concentrations of
0.5 mM GST-MIBD and 2 mM GST. Baselines were collected
for PBS and subtracted from the scans of GST-MIBD samples.
Data were analysed using the Microcal Origin Software (version
4.0). Each sample was heated and cooled for five cycles to evaluate
folding reversibility. Unfolding of the protein was irreversible and
accompanied by precipitation.
Transwell migration assays
CHO B2 cells lacking α5 as well as CHO B2a27, its α5 trans-
fectant [21], were transiently transfected with full-length nis-
charin (pcDNA-mycNis) and its truncations (pcDNA myc-IBD,
pcDNA myc-MIBD, pcDNA myc-NIBD) or vector control using
LIPOFECTAMINETM (Invitrogen). Cell migration studies were per-
formed using a transwell assay, according to a previously des-
cribed procedure [17]. The transfected cells were marked using a
β-galactosidase expression plasmid. The underside of each trans-
well was coated with 10 µg of fibronectin or vitronectin; the cells
were plated on the upper surface and the percentage of full-length
nischarin, truncated forms of nischarin or control transfectants
migrating across the 8 µm pore-size membrane was determined
by staining for β galactosidase after overnight incubation in BSA-
containing medium. The ratio of migrant transfected cells to total
transfected cells ×100 was taken as the percentage of migration.
RESULTS
Construction of IBD and α5 truncations
To map the minimal interaction region on the α5 cytoplasmic tail
as well as on the IBD of nischarin, we prepared 17 constructs
(see the Materials and methods section). Of these, six were α5
mutants and 11 were nischarin IBD mutants. As described in
the Materials and methods section, seven different N-terminal
IBD-truncated constructs and four C-terminal truncations were
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Figure 1 Schematic representation of the IBD of nischarin and of α5 cytoplasmic domain truncations
(A) Amino acid sequence and schematic representation of IBD-truncated constructs. The wild-type amino acid sequence of the previously described IBD is shown, the truncated analogues are depicted
and the starting and ending amino acid numbers are shown. These truncations were created by PCR approach using the primers described in Table 1. (B) Amino acid sequence of α5-truncated
constructs. These constructs were prepared using the primers described in Table 2. The names of the constructs are shown to the right in (A) and (B).
made by PCR approaches (Figure 1A). Furthermore, three α5
N-terminal and three C-terminal truncations were made (Fig-
ure 1B).
Yeast-two-hybrid analyses
Characterization of α5 binding sites in the IBD of nischarin
Several IBD truncations described above were tested against the
α5 cytoplasmic tail using a two-hybrid analysis. As reported
previously, the originally described [17] IBD of nischarin interacts
strongly with the α5 cytoplasmic region, but not the vector control
or other α subunits (Figure 2, position #12, [17]). Fragments of
nischarin with N-terminal truncations (trunc1: 445–581, trunc2:
452–581, trunc3: 462–581; Figures 2B and 2C, positions #1–3)
also interacted strongly with the α5 cytoplasmic region, whereas
trunc 4 (473–581) did not interact (Figures 2B and 2C, position
#7). To identify further the exact region of interaction, three other
constructs including trunc 3.1 (464–581), trunc 3.2 (467–581)
and trunc 3.3 (470–581) were made. Trunc 3.2 and trunc 3.3 (po-
sitions #5 and 6) were unable to interact, whereas trunc 3.1
(position #4) was able to interact (Figures 2B and 2C), suggesting
that truncations beyond 467 amino acids disrupted the interaction.
To demarcate the C-terminal boundary of the region, C-terminal
truncations were created. C-terminal fragments, truncs 11 (435–
571) and 12 (435–562), interacted well (Figure 2, positions #8
and 9), whereas truncs 13 (435–551) and 14 (435–541) did not
c© 2004 Biochemical Society
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Figure 2 Two-hybrid analysis to identify minimal region of nischarin necessary for interaction with α5 integrin cytoplasmic tail
Yeast cells were transformed with pBTM-α5 and selected for tryptophan prototrophy. Tryptophan-positive cells were again transformed with truncs 1 (position #1), 2 (position #2), 3 (position #3),
3.1 (position #4), 3.2 (position #5), 3.3 (position #6), 4.0 (position #7), 11 (position #8), 12 (position #9), 13 (position #10), 14 (position #11) or vector control constructs (position #12) (described
in Table 1 and Figure 1A), and screened for tryptophan and leucine prototrophy by growing them on plates that lack leucine and tryptophan (-TL) (A). The cells that grew on -TL were replica-plated
on to plates that lack tryptophan, leucine and histidine residues (B). The cells in (A) were also transferred to a filter, and X-gal staining was performed to confirm the interactions further. Only cells
with strong interaction turn blue under these conditions (C).
Figure 3 Two-hybrid analysis to identify minimal region of α5 necessary for interaction with nischarin
L40 yeast strain was transformed with pVP-IBD plasmid and selected for leucine prototrophy. The yeast cells that contain the pVP-IBD plasmid were transformed with wild-type α5 (position #1), α2
(position #2), trunc 1 (position #3), trunc 2 (position #4), trunc 3 (position #5), mutant (position #6), trunc 11 (position #7), trunc 12 (position #8) or trunc 13 (position #9) constructs (described in
Table 2 and Figure 1B), and selected for leucine and tryptophan prototrophy. All transformed cells grow well under these conditions (A). The same cells in (A) were replica-plated on to plates that
lack histidine in addition to leucine and tryptophan (B). The same cells in (A) were transferred to a filter paper and stained for β-galactosidase (C).
(Figure 2, positions# 10 and 11). C-terminal truncations of the
region up to amino acid 462 retained α5 binding, since both
truncs 11 (435–571) and 12 (435–562) bound to α5. Deletion of
amino acids from the C-terminus beyond residue 561 disrupted
α5 interaction. These results suggest that deletions beyond amino
acids 464–562 were not dispensable for interaction. Thus the
region (amino acids 464–562) was designated as MIBD.
Characterization of nischarin-binding sites in the cytoplasmic domain of α5
The α5 tail fragments were subcloned into pBTM bait vector,
and co-transfected with pVP-nischarin IBD constructs (Fig-
ures 1B and 3). As reported previously, IBD interacted with the
full-length α5 cytoplasmic tail (Figure 3, position #1), whereas
the α2 cytoplasmic tail did not interact (Figure 3, position #2). The
α5 N-terminal truncations, namely trunc 1 (lacks IYILY), trunc 2
(lacks IYILYKL) and trunc 3 (lacks IYILYKLGFFKR), failed to
interact with the IBD of nischarin (Figure 3, positions #3–5). In
the C-terminal mutants, deletion of residues beyond GFFKRSL
seems to be dispensable for the interaction, as these mutants
strongly interacted with the IBD (truncs 11–13) (Figure 3,
positions #7–9). The GFFKR region is one of the most highly
conserved regions of the peptide among different integrin α
subunits. Thus we created a mutant that lacks only KLGFFKRSL
(Figure 1B). This mutant was unable to interact with the IBD
of nischarin (α5 mutant) (Figure 3, position #6). These results
indicate that neither IYILYKL nor GFFKRSL alone can interact
with nischarin and the entire region of IYILYKLGFFKRSL
(residues 1017–1030 of α5 integrin) is required for nischarin
binding.
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The BIAcore assay for interaction between nischarin and α5
Recombinant nischarin proteins (GST-IBD, GST-MIBD and GST-
NIBD) and GST alone were purified as described in the Materials
and methods section. The interaction of these proteins with α5
was further examined using a BIAcore assay which has been
widely used to detect protein–protein interactions [19,20]. Our
experiments used α5 peptides conjugated to biotin at their N-
terminus (Table 4). A total of eight peptides of α5 were analysed
for their binding capacity to nischarin-fusion proteins. As a
positive control, we used a wild-type α5 sequence (peptide 1),
whereas a scrambled peptide served as a negative control. The
biotinylated peptides were immobilized via a biotin group bound
to the streptavidin biosensor surface. The recombinant GST-IBD
(results not shown) or GST-MIBD nischarin proteins were flowed
over the complex. As a control, the analyte buffer containing GST
alone or GST-NIBD (a region that cannot bind to nischarin) was
injected.
As expected, GST-MIBD (residues 464–562) bound strongly
to peptide 1 (IYILYKLGFFKRSL) (Figure 4A), whereas GST
alone did not interact. Both GST-NIBD (results not shown) and
GST alone displayed negligible binding to peptide-immobilized
streptavidin chip (Figure 4A, bottom panel). Analysis of the
sensorgrams demonstrated that peptide 1 (IYILYKLGFFKR), but
not scrambled peptide, was able to bind to GST-MIBD (Fig-
ure 4A). Thus nischarin interacts directly with α5 peptides. To
identify which residues are important for binding, a series of
mutated peptides were examined by a surface-plasmon resonance
approach. First, we attempted to determine if either of the tyrosine
residues in the 1017IYILYKL1023 region is important for the binding;
thus both tyrosine residues were mutated to alanine residues. The
membrane-distal tyrosine (residue 1021; peptide 2) did not have
any effect on binding. However, membrane proximal substitution
of tyrosine (residue 1018; peptide 3) affected binding significantly
(Table 4, Figure 4A), indicating that this region might be important
for binding to nischarin. Lysine is highly conserved among all α
and β subunits and predicted to play a role in exposing the
cytoplasmic tail for interactions with cytoplasmic proteins [22].
Thus we mutated this residue; substitution of alanine for lysine
(residue 1022; peptide 4) resulted in almost complete loss of
binding (Figure 4B), indicating that this residue is critical for
interaction. Both GST-NIBD and GST alone failed to bind
peptides on the chip (results not shown).
Several conserved features constitute the cytoplasmic tail of in-
tegrin, including the highly conserved GFFKR region. To our sur-
prise, single mutations in the GFFKRSL region did not have any
effect on binding to nischarin. As shown in Figure 4(C),
substitution of alanine for lysine (residue 1027; peptide 5), and
Figure 4 GST-IBD of nischarin binding to α5 peptides as assessed by
surface-plasmon resonance
(A) Top panel: Membrane-proximal Tyr1018 of α5 is important for binding to nischarin.
Peptides IYILYKLGFFKRSL (1), IYILAKLGFFKRSL (2), IAILYKLGFFKRSL (3) or FGFLKYKLIRYSI
(scrambled peptide, SC) were immobilized to streptavidin-coated biosensor surfaces and 60 µl
of 50 nM GST-MIBD was injected (time, 360 s; flow rate, 10 µl/min). Background for binding of
nischarin to the scrambled peptide has been subtracted. RU, resonance units; time in S. Bottom
panel: the same biosensor surfaces in (A), top panel, were stripped, and GST alone was injected.
(B) Lys1022 is important for interaction. Peptides IYILYKLGFFKRSL (1), IYILYALGFFKRSL (4), or
FGFLKYKLIRYSIL (SC) were immobilized to strepatavidin-coated surface and 50 nM of GST-
MIBD was injected as in (B). (C) Single mutations in GFFKR region did not strongly affect binding.
IYILYKLGFFARSL (5), IYILYKLGFFKASL (6), or IYILYKLGFFKRAL (7) were immobilized as above,
and GST-MIBD was injected. (D) Quantification of BIAcore data: SPR data of seven peptides
were converted into Microsoft Excel, and values of peptide binding peaks were plotted. Binding
of peptides 3 and 4 are significantly low compared with peptide 1. For peptide 3, ∗P < 0.005
(P = 0.003); for peptide 4, ∗∗P < 0.0005 (P = 0.0004). Results are the means +− S.E.M. from
three determinations.
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alanine for arginine (residue 1028; peptide 6) and alanine for
serine (residue 1029; peptide 7) had no significant decrease
in binding to IBD of nischarin. These results further support
that the membrane-proximal 14-amino-acid residue of the α5
cytoplasmic domain contains the binding site for nischarin, and
reveals that residues Tyr1018 and Lys1022 are important for nischarin
binding. Our results show that nischarin MIBD binds strongly to
α5 peptides. We were not able to calculate affinity constants.
However, size-exclusion chromatography revealed that GST-
MIBD was a dimer (see below) rather than a monomer. Thus,
we could not obtain meaningful dissociation constants. However,
in semi-quantitative terms, it is clear that peptides 3 (mutation of
residue 1018) and 4 (mutation of residue 1022) have significantly
lower binding than the other α5 peptides (Figure 4D).
DSC experiments
Since the GST-fusion proteins were initially insoluble, we per-
formed several biophysical experiments to examine the nature of
these proteins. Gel-filtration chromatography experiments reve-
aled that the GST-MIBD exists as a monodisperse dimer (results
not shown), similar to the GST protein that is known to exist as
a dimer [23–25]. Also, we have examined whether GST-MIBD
is a folded domain by DSC experiments. The proteins were heated
at a scanning rate of 60 ◦C/h up to 95 ◦C, cooled and rescanned
under the same conditions. The peak of a DSC curve yields the
melting temperature (Tm) for denaturation. GST thermally dena-
tured as a single peak in DSC at approx 58 ◦C (Figure 5). The
unfolding of GST-MIBD showed two peaks, one with a midpoint
at approx 58 ◦C and the other at approx 82 ◦C, probably re-
presenting GST and MIBD domains respectively. The DSC
profile for MIBD showed a broad unfolding transition, which
is somewhat similar to the curve shown by Garcia-Mira et al.
[26], indicating that unfolding probably started at even lower tem-
peratures. The observed transitions were irreversible as no tran-
sitions were noticed in subsequent scans. Heating of the sample
above 80 ◦C leads to complete and irreversible denaturation of
GST-MIBD.
In DSC, most proteins were not able to re-fold after heat de-
naturation, especially for proteins larger than 20 kDa [27].
Irreversible thermal denaturation has also been observed in several
MHC proteins [28]. Thus, our results revealed the structural
stability of the fusion proteins and suggest that MIBD is a folded
domain.
Migration effects
Although it is clear that nischarin plays an important role in the
regulation of cell migration, the role of the IBD is not known. To
elucidate the role of the MIBD in cell migration, we performed
cell migration assays using the IBD, MIBD or NIBD of nischarin.
Surprisingly, none of these moieties had any effect on haptotactic
migration on fibronectin and on vitronectin, whereas full-length
nischarin was capable of inhibiting cell migration on fibronectin,
as reported in [17] (Figure 6). In addition, migration of B2 cells
(that lack α5) on vitronectin was not affected by any of these
constructs. These results indicate that the IBD is not sufficient for
the migration inhibitory effects of nischarin, and thus the other
regions of this protein may be necessary for this function.
DISCUSSION
We identified nischarin as a protein that binds selectively to the
α5 integrin subunit and inhibits cell migration. Since nischarin
selectively affects cell migration on fibronectin, and binds α5β1
Figure 5 DSC thermograms
DSC was performed in PBS at 1 ◦C/min, and from 20 to 95 ◦C. For clarity, starting values of C p
(cal\◦C) on the y-axis were normalized to zero. (A) Thermal denaturation profile of (A) GST-
MIBD (protein concentration was 0.5 mM) and (B) GST (protein concentration was 2 mM).
Figure 6 Migration is not affected by the nischarin IBD
Transwell migration assays were performed using α5-deficient CHO B2 cells or α5 overex-
pressing CHO B2α27 cells transfected with full-length nischarin (Nis) (pcDNA-Myc nischarin),
pcDNA-Myc IBD, pcDNA-Myc MIBD or pcDNA-Myc NIBD. Cells migrating either on fibro-
nectin (FN) or vitronectin (VN) were counted and plotted. Results represent means +− S.E.M.
from three determinations. Vec, vector (control).
integrin, it is of interest to identify the minimal α5 binding
region on nischarin, and the nischarin-binding region on the cyto-
plasmic domain of the α5-integrin subunit. Nischarin is the only
c© 2004 Biochemical Society
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protein known to date, which interacts selectively with the
integrin-α5 subunit. Previously, we reported [17] that a 147 amino
acid residue nischarin IBD directly binds to the cytoplasmic
tail of α5. In the present study, we have demonstrated that
another 51 amino acids are dispensable for this interaction; thus
we have identified 99 residues as the minimal binding domain
of nischarin for α5. Also, we mapped the nischarin-binding site
on the α5 cytoplasmic domain to a 14-residue stretch that includes
membrane-proximal as well as putative intra-membrane portions
of the α5-integrin subunit. BIAcore surface-plasmon resonance
experiments allowed monitoring of interactions between a recom-
binant MIBD and various truncated α5 cytoplasmic tail peptides.
We have identified residues Tyr1018 and Lys1022 (IYILYKL-
GFFKRSL) to be important in nischarin–α5 interaction. This
is somewhat surprising since the IYILYKGFF sequence is
thought to be partially within the membrane [22]; however, some
soluble proteins penetrate membranes [29], and this may allow
interactions with intra-membrane sequences. Several possibilities
for the interaction of this region with cytosolic proteins have
been proposed by Armulik et al. [22]. It was suggested that the
region is pushed out of the membrane when its hydrophobicity
is decreased; Lys1022 is highly conserved in all integrin subunits,
and it is believed that this residue may facilitate the entry of
the adjacent residues into the cytosol. Another possibility is
that the region is buried in the membrane when integrins are in
inactive conformation and on activation these will be accessible
to intracellular proteins. Thus it is possible that nischarin interacts
with α5 at the membrane-proximal sequence through one of
the scenarios described [22]. Interestingly, the interacting region
contains a membrane-proximal IYILY region that is exclusively
present in the α5 subunit; this explains the reason for selective
binding to α5 cytoplasmic tail as demonstrated by us previously
[17].
This is consistent with other reports demonstrating the im-
portance of integrin-membrane-proximal regions in association
with other membrane or cytoplasmic proteins [30]. Talin is a cyto-
skeletal protein that connects integrins to the actin cytoskeleton.
Talin has been shown to interact with peptides from the mem-
brane-proximal region of β3 integrin [31]. The membrane-
proximal NPXY motif of the β3 cytoplasmic tail is essential for
talin binding [32]. Interaction of the membrane-proximal region of
β3 with integrin leads to integrin activation [33]. More precisely,
a FERM (four point one, ezrin, radixin and moesin) domain of the
head domain of talin has been shown to bind to the β3 cytoplasmic
tail, and is important in integrin linkage to the interior of the cell
[34]. F3, a subdomain of FERM, induces activation of integrin
αIIbβ3 and in turn may control cell migration [32]. These results
suggest that association of integrins with cytoplasmic proteins
plays a major role in integrin activation and regulation of cell
migration.
Most of the integrin subunit cytoplasmic domains are relatively
small (20–70 residues), with the exception of the β4 integrin
cytoplasmic domain. A deletion of seven membrane-proximal
amino acids resulted in the activation of integrin αIIb, which
further suggests that membrane-proximal residues are important
for integrin function [35,36]. Cytohesin 1 has been shown to
interact with the nine membrane-proximal amino acids of the β2
cytoplasmic tail [37]. In contrast, ICAP1α (integrin cytoplasmic
domain-associated protein-1α) has been shown to bind to the C-
terminus of the integrin β1 subunit [38]. Recently, a binding site
for the calcium- and integrin-binding protein has been mapped to a
15-amino-acid membrane-proximal region of αIIb (some residues
in the region are thought to be embedded in the membrane) [30].
The KVGFFKR sequence of αIIb has been shown to be necessary
but not sufficient for the α-β heterodimerization [39–41]. More
recently, it was shown that transmembrane helix-cytoplasmic
domain of β3 regulates changes in the αIIbβ3 activation state [42].
At present, we do not know whether nischarin has a regulatory
effect on α5β1 ligand-binding function and/or in post-receptor
occupancy events; these possibilities need further exploration.
It has been shown that several integrin cytoplasmic domain-
binding proteins regulate several aspects of signal transduction
and cell migration. For instance, ICAP1 has been shown to
regulate cell adhesion and cell migration [43,44]. Also paxillin
binding to the α4 integrin cytoplasmic tail selectively inhibits cell
migration [16]. Previously, we reported that full-length nischarin
inhibits α5-dependent cell migration [17]. We tested whether the
minimal-binding region (99 amino acids) of nischarin is sufficient
for this inhibition. As shown in Figure 6, neither the 147-residue
fragment nor the 99-residue fragment was able to inhibit migration
of CHO cells overexpressing α5 integrin, indicating that other
regions of nischarin contribute to its motility inhibitory ability.
In summary, in the present study, we have mapped the α5
integrin-binding region in nischarin and the nischarin binding
region in α5 integrin. We found that (1) a region of residues bet-
ween Lys464 and Arg562 is sufficient for binding to the α5 cyto-
plasmic tail; (2) the IYILYKLGFFKRSL sequence is sufficient
for binding to the IBD of nischarin and Tyr1018 and Lys1022 are
crucial for this interaction; and (3) the 99-residue fragment that
binds to the α5 cytoplasmic domain is not sufficient for inhibition
of migration. Thus, it will be important to examine how the IBD of
nischarin works with other regions of this protein to provide the
full biological activity of the molecule. Also this knowledge
will be helpful for future structural and functional studies of
nischarin.
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